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Abstract 
A simple procedure for the quantitative determination in hair samples of 13 common drugs of 
abuse or metabolites (morphine, 6-acetylmorphine, codeine, amphetamine, methamphetamine, 
3,4-methylenedioxyamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-
methylenedioxyethylamphetamine, benzoylecgonine, cocaine, buprenorphine, methadone and Δ9-
tetrahydrocannabinol) has been developed and fully validated. The analytes were extracted from 
the matrix by a simple overnight incubation with methanol at 55 °C. An aliquot of the extract was 
directly injected into an ultra-high performance liquid chromatography system equipped with 
Waters Acquity UHPLC BEH C18 column (100 mm × 2.1 mm, 1.7 μm). The mobile phase eluted 
with a linear gradient (water/formic acid 5 mM:acetonitrile; v:v) from 98:2 to 0:100 in 4.5 min, 
followed by isocratic elution at 100% B for 1.0 min. The flow rate was 0.6 mL/min and the total run 
time was 8.0 min including re-equilibration at the initial conditions. The compounds were revealed 
by a triple quadrupole mass spectrometer operating in the selected reaction monitoring mode. The 
absence of matrix interferents, together with excellent repeatability of both retention times and 
relative abundances of diagnostic transitions, allowed the correct identification of all analytes 
tested. The method proved linear in the interval from the limit of quantification to 5.0 ng/mg 
(1.0 ng/mg for Δ9-tetrahydrocannabinol) with correlation coefficient values ranging from 0.9970 to 
0.9997. Quantitation limits were below the cut-off values recommended by the Society of Hair 
Testing and ranged from 0.02 to 0.08 ng/mg. Application of the present UHPLC–MS/MS procedure 
and instrumentation to hair analysis allows high sample-throughput, together with excellent 
sensitivity and selectivity, in workplace drug-screening controls and forensic investigations. These 
qualities, combined with minimal sample workup, make the cost of this screening affordable for 
most private and public administrations. 
 
Highlights 
► Hair analysis is a tool to evaluate drug exposure in several application fields. ► We present a 
simple UHPLC–MS/MS method to detect 13 common drugs of abuse in hair. ► The method proved 
excellent analytical performances and drastic reduction of time. ► High sample throughput is 
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The determination at low concentration of common psychotropic drugs is increasingly requested in 
hair samples for the retrospective investigation of habitual drug abuse and dependence as well as 
in other toxicological investigations [1]. Nowadays, hair analysis is a widely used tool to evaluate 
drug exposure in several application fields, such as workplace drug testing, driving re-licensing, 
drug abuse history and withdrawal control, drug-facilitated crimes, post-mortem toxicology, pre-
natal exposure to drugs, doping control, therapeutic drug monitoring of 
pharmaceuticals [2], [3], [4], [5], [6], [7], [8], [9] and [10]. To meet the high demand for drug 
screening in hair samples, toxicology laboratories are forced to update their procedures, in order to 
target an increasing number of drugs but also achieve rapid, simple and sensitive analyses with 
reduced work for sample preparation and instrumental processing, so as to increase overall 
sample-throughput. Different methods have been proposed for testing class-specific groups of 
compounds, but only a few papers describe extensive screening of multiclass 
drugs [11], [12] and [13], among which Δ9-tetrahydrocannabinol (THC) was never included. The 
various analytical methods employed to test hair extracts for abused drugs have been recently 
reviewed [14]. These methods include derivatization followed by gas chromatography/chemical 
ionization mass spectrometry [15], liquid chromatography with various mass spectrometers, such 
as triple quadrupoles [16], ion traps [17], time-of-flight [18] and hybrid linear ion trap-orbitrap mass 
spectrometers [19]. The use of direct mass spectrometric techniques such as ambient ionization 
mass spectrometry [20] and matrix-assisted laser desorption ionization mass spectrometry 
(MALDI-MS) [21] have also been described for hair drug testing. 
Most of the cited methods were implemented for the determination of a few analytes, as is evident 
from the synoptic table reported in the cited review [14]. In order to perform wide range screening 
of abused drugs, more than one procedures are likely to be utilized, with direct impact on efficiency 
and costs. In particular, extensive application of hair analysis in workplace drug testing is often 
prevented by its cost, crucially high for public administrations. 
Our goal was to develop and validate a sensitive multi-class and multiresidual screening method 
for drugs of abuse or metabolites in hair samples using a dedicated UHPLC–MS/MS protocol. In 
comparison with the previously reported procedures, the present method used a simple sample 
extraction and direct injection into the UHPLC–MS system, avoiding both solid-phase and liquid–
liquid extraction. Furthermore, the utilization of recent UHPLC–MS/MS technology allowed a 
drastic reduction of the analysis time, without resolution loss. The method proved simple, accurate, 
rapid and highly sensitive, allowing the simultaneous detection of all the most common drugs, 





2.1. Chemicals and reagents 
Morphine, 6-monoacetylmorphine (6-MAM), codeine, amphetamine, methamphetamine, 3,4-
methylenedioxyamphetamine (MDA), N-methyl-3,4-methylenedioxymethamphetamine (MDMA), 
3,4-methylenedioxyethylamphetamine (MDEA), benzoylecgonine (BZE), cocaine, buprenorphine, 
methadone, Δ9-tetrahydrocannabinol (THC), cocaine-d3 (COC-d3), amphetamine-d6 (AMP-d6), 
morphine-d3 (MOR-d3), benzoylecgonine-d3 (BZE-d3), 11-nor-9-carboxy-Δ9-tetrahydrocannabinol-
d3 (THCmet-d3) were purchased from LGC Promochem (Milan, Italy). Dichloromethane, methanol, 
formic acid, acetonitrile were provided by Sigma–Aldrich (Milan, Italy). Ultra-pure water was 
obtained using a Milli-Q® UF-Plus apparatus (Millipore, Bedford, MA, USA). Stock standard 
solution were stored at −20 °C until used. Working standard solutions were prepared at 10 μg/mL 
final concentration by dilution with methanol. 
 
2.2. Sample preparation 
About 50 mg of hair was twice-washed with dichloromethane (2 mL, vortex mixed for 3 min). After 
complete removal of solvent wash, the hair was dried at room temperature by a gentle nitrogen 
flow and subsequently cut with scissors into 1–2 mm segments. Hair samples were fortified with 
2 μL of an internal standards mixture yielding a final concentration of 0.6 ng/mg. After the addition 
of 2 mL of methanol, the samples were incubated at 55 °C for 15 h without stirring. Lastly, the 




Analyses were performed using a Shimadzu LC-30A Series system (Shimadzu, Duisburg, 
Germany), interfaced to an API 5500 triple quadrupole mass spectrometer (Applied 
Biosystem/Sciex, Darmstadt, Germany) equipped with an electrospray Turbo Ion source operating 
in positive-ion mode. A Waters Acquity UHPLC BEH C18 column (100 mm × 2.1 mm, 1.7 μm), 
protected by a C18 guard column, was used for the target analytes separation. The column oven 
was maintained at 50 °C and the elution solvents used were water/formic acid 5 mM (solvent A) 
and acetonitrile (solvent B). The mobile phase eluted under the following linear gradient conditions 
(A:B; v:v): from 98:2 to 0:100 in 4.5 min, followed by isocratic elution at 100% B for 1.0 min. The 
flow rate was 0.6 mL/min and the total run time was 8.0 min including re-equilibration at the initial 
conditions. The mass analyzers were operated in the selected reaction monitoring (SRM) mode. In 
order to establish appropriate SRM conditions, optimization of the mass spectrometer was 
conducted by direct infusion of the analytes into the electrospray ionization capillary and the 
declustering potential (DP) was adjusted to maximize the intensity of the protonated molecular 
species. The collision offset (CE) voltage values were selected so as to preserve approximately 
10% of each precursor ion. Nitrogen was employed as the collision gas (5 × 10−3 Pa). The ESI 
source was held at 550 °C. Precursor ions and the corresponding product ion SRM transitions 
employed for all analytes and internal standards are presented in Table S1, supplementary data. 
 
2.4. Method validation 
The method was validated for linearity, selectivity, quantitation limits (LOD and LOQ), intra/inter-




A pool of five different blank hair samples obtained from different healthy volunteers (two females, 
three males) was prepared and analyzed as described above. The occurrence of possible 
interferences from endogenous substances was tested by monitoring the SRM chromatograms 
characteristic for each investigated compound at the expected retention time interval. 
 
2.4.2. Identification criteria and repeatability of diagnostic fragment ions relative abundances 
Identification criteria for the analytes were established according to CE/2002/657 decision and 
2006 SOFT/AAFS guidelines criteria [22]. The repeatability of relative peak intensities for the 
transitions of each analyte was determined on five spiked hair samples at three concentration 
levels (0.2, 1.0 and 5.0 ng/mg; 0.04, 0.2 and 1.0 ng/mg for THC). Retention time precision at each 
concentration was also determined. 
 
2.4.3. Linearity, limit of detection and limit of quantitation 
The linear calibration model was checked by analyzing (three replicates) blank hair samples spiked 
with standard solutions at six concentration levels for each analyte (Table 1). Linearity was 
evaluated using the least squares regression method. Quantitative data resulting from area counts 
were corrected using the IS signal areas. The limit of detection (LOD) was estimated as the analyte 
concentration whose response provided a S/N value equal to 3, as determined from the least 
abundant among the qualifier ions; LOD was extrapolated from S/N values of the three lowest 
concentrations of the calibration curve. The calculated LODs were then experimentally confirmed 
by analyzing spiked samples at LODs concentration for all analytes. The limit of quantification 





Table 1. Calibration levels, R2 values for calibration curve and matrix effect; LODs and 














    Mean 
(±%) 
CV%   
Morphine MOR-d3 0.20–5.0 0.9985 −6.7 4.7 0.009 0.03 
Codeine MOR-d3 0.20–5.0 0.9991 −14.1 7.0 0.012 0.04 
Amphetamine AMP-d6 0.20–5.0 0.9980 +0.2 5.6 0.027 0.08 
6-MAM MOR-d3 0.20–5.0 0.9985 −3.9 4.9 0.007 0.02 
MDA AMP-d6 0.20–5.0 0.9990 +0.7 6.5 0.021 0.06 
Methamphetamine AMP-d6 0.20–5.0 0.9997 −2.8 6.4 0.011 0.03 
MDMA AMP-d6 0.20–5.0 0.9987 +0.6 9.3 0.006 0.02 
MDEA AMP-d6 0.20–5.0 0.9970 +1.6 3.0 0.012 0.04 
Benzoylecgonine BZE-d3 0.20–5.0 0.9994 −4.3 4.1 0.007 0.02 
Cocaine COC-d3 0.20–5.0 0.9987 −4.7 12.8 0.011 0.03 
Buprenorphine MOR-d3 0.20–5.0 0.9986 −2.7 11.6 0.027 0.08 
Methadone BZE-d3 0.20–5.0 0.9982 +1.0 5.9 0.011 0.03 
THC THCmet-
d3 
0.04–1.0 0.9981 −21.6 24.9 0.012 0.04 




2.4.4. Matrix effect 
The matrix effect was calculated as the mean value obtained from five different hair sources. Hair 
samples were spiked after the extraction step at the final concentration of 1.0 ng/mg (0.2 ng/mg for 
Δ9-THC). For each analyte, the chromatographic peak area was compared with the peak area of 
standard solutions prepared in methanol. For each sample, analyses were repeated three times. 
Variability of matrix effect among different hair samples was expressed as CV%. 
 
2.4.5. Precision and accuracy 
For all analytes, intra-day precision (expressed as percent variation coefficient, CV%) and 
accuracy (expressed as bias %) were evaluated at LOQ and at different concentration levels. Ten 
replicates of blank hair samples spiked with the standard solutions at the final concentration of 
LOQs, 0.2, 1.0 and 5.0 ng/mg (0.04, 0.2 and 1.0 ng/mg for Δ9-THC) and analyzed by the described 
method. Inter-day precision and accuracy were evaluated by preparing and analyzing for three 
consecutive days one set of ten hair samples spiked with target compounds at LOQ and at the final 
concentration of 1.0 ng/mg (0.2 ng/mg for Δ9-THC). Standard criteria designated satisfactory assay 
precision when CV% values were below 25% for lower concentrations and below 15% for upper 
concentrations. Satisfactory accuracy was achieved when the experimentally determined 
concentrations lied within ±25% from the expected values. Bias % (%B) was estimated as the 
percent difference between the average value of a set of measurements (X) and the “true value” 
(T) following the formula %B = (100/T) × (X − T). The parameters most commonly changing in 
everyday toxicological analysis, namely sample volume, reagent batch and operator, were 
deliberately varied to test if satisfactory accuracy was maintained. 
 
2.4.6. Carry-over 
The background chromatographic profiles for each analyte were monitored during the analysis of 
blank hair sample injected for five times after the chromatographic run of a spiked blank hair 
sample containing all the analytes at 5.0 ng/mg concentration. To assure the absence of carry-
over, the signal to noise ratio (S/N) for each transition had to be lower than 3. 
 
3. Results and discussion 
 
3.1. Method validation 
 
3.1.1. Selectivity 
The SRM chromatograms obtained from five blank hair samples presented no peaks arising from 
endogenous interferences (i.e. S/N < 3) at the expected retention time for all analytes. This 
demonstrated that the method is selective for the tested compounds and free from positive 
interference from hair components and column bleeding. 
 
3.1.2. Identification criteria 
The SRM transitions selected for each analyte provided at least 4 identification points, while the 
substantial stability of their relative abundances proved compliant to the unambiguous identification 
of all analytes included in the assay, in agreement with CE/2002/657 decision and 2006 
SOFT/AAFS guidelines criteria[22]. Moreover, the intra-day precision values for retention times 
measured at 0.2, 1.0 and 5.0 ng/mg concentration (0.04, 0.2 and 1.0 ng/mg for THC) were below 





3.1.3. Linearity, limit of detection and limit of quantitation 
The SRM protocol described (see Table S1) was used to build the calibration plots for all thirteen 
analytes. Adequate linearity was observed for all compounds. Table 1 reports the 
resulting R2 values, ranging from 0.9970 and 0.9997 and indicating good fit and linearity of the 
calibration curves. Table 1 also reports LOD and LOQ values, calculated from the analysis of 
multiple blank samples. Detection of analytes at LOD levels was confirmed experimentally 
(see Fig. 1). LOD values ranged between 0.006 ng/mg and 0.027 ng/mg while LOQ values were 
estimated between 0.02 ng/mg and 0.08 ng/mg. When compared to existing procedures using 
similar techniques [14], the present method provided equal or lower LODs and LOQs. This 
demonstrates that the inclusion of a large set of analytes within the screening protocol and the 
simplified sample treatment did not affect significantly the method sensitivity, while the newest 
UHPLC technology coupled with the last generation of mass spectrometers guarantees short 




Fig. 1.  MRM chromatograms of a blank hair sample spiked at LOD. 
 
 
3.1.4. Matrix effect 
The variability among different hair samples was acceptable (CV% <25%, as shown in Table 1), in 
consequence we pooled together the five sources of hair to perform validation experiments such 
as precision and accuracy. The effect of real hair matrix did not appear significant for most of the 
analytes tested (see Table 1). A moderate ion suppression was observed for morphine, 6-MAM, 
benzoylecgonine and cocaine, while the matrix influence was minor for methadone, all the 
amphetamines and buprenorphine. Only codeine and Δ9-THC underwent a considerable ion 
suppression from keratinic matrix (values <−10%). To compensate as much as possible the matrix 
effects present in real hair samples analysis, all calibration and validation tests were conducted on 
a pool of human hair samples, spiked with standard analytes solutions. The good linearity 
observed in the calibration plots demonstrated however that the observed matrix effect is 
proportionally constant, i.e. does not depend on the analytes’ concentrations. 
 
3.1.5. Precision and accuracy 
Intra- and inter-day data on precision and accuracy are reported in Table 2. The results show 
satisfactory intra-day repeatability, as the percent variation coefficient (CV%) is lower than 15% for 
all the spiked analytes at LOQ, low, medium and high concentration. In particular, intra-day 
precision exhibits CV% values ranging between 0.7% and 14.9%. 
 
Table 2. Intra/inter-day precision (CV%) and accuracy (bias %) for each analyte tested. 
Compound Intraday (n = 30) 
 
Interday (n = 30) 
 








 LOQ Lowa Mediumb Highc LOQ Lowa Mediumb Highc LOQ Mediumb LOQ Mediumb 
Morphine 8.1 3.9 4.4 3.5 −18.5 +6.0 −5.4 −13.3 8.8 9.9 −24.3 +8.4 
Codeine 6.4 3.2 2.6 3.9 −8.0 +10.0 +3.0 −13.2 7.4 8.1 −22.0 −8.4 
Amphetamine 5.8 6.3 5.2 9.7 +10.0 +4.0 −2.2 −12.8 5.4 12.0 +5.6 +18.4 
6-MAM 14.9 5.0 6.2 2.4 −14.0 +9.0 +7.0 −10.8 17.4 11.0 −14.8 +16.4 
MDA 8.1 7.1 5.3 5.9 +3.5 −1.0 −1.0 −6.7 9.1 11.6 −3.0 +4.8 
Methamphetamine 13.0 2.6 4.7 5.6 +47.5 +7.0 +10.2 −12.5 21.5 15.5 +52.8 +12.8 
MDMA 2.7 5.7 0.7 5.6 +22.0 −4.0 +14.8 −13.8 25.3 16.9 +31.3 +6.0 
MDEA 2.6 10.9 8.8 4.4 +14.0 −1.0 +18.0 −11.0 5.5 22.5 +16.0 +14.8 
Benzoylecgonine 1.4 3.9 9.0 4.6 −18.0 +6.0 +8.0 +0.5 4.9 17.8 −22.7 +18.0 
Cocaine 3.0 9.9 4.7 4.5 +15.0 +9.0 +14.8 −6.5 5.1 12.0 +10.7 −6.4 
Buprenorphine 6.7 2.7 2.7 6.9 −3.0 +3.0 −4.2 −9.8 4.3 22.4 −2.2 +9.2 
Methadone 7.7 7.5 4.8 5.9 +18.5 +9.0 +9.4 −2.2 10.3 9.4 +26.3 +19.6 
THC 12.4 12.4 4.1 5.9 +10.0 +10.0 +1.0 −3.0 20.0 10.8 +14.0 +6.0 
aLow concentration: 0.2 ng/mg (0.04 ng/mg for THC). 
bMedium concentration: 1.0 ng/mg (0.2 ng/mg for THC). 
cHigh concentration: 5.0 ng/mg (1.0 ng/mg for THC).
The intra-day accuracy results proved better than acceptable in most cases, particularly at the 
lowest concentration tested, where percent bias values ranged from −4.0% (MDMA) to +10.0% 
(codeine and THC). This upshot is particularly significant, as the 0.2 ng/mg level correspond to the 
generally accepted cut-off for many analytes, such as opiates, methadone and amphetamines. 
Indeed, high accuracy at cut-off levels is an essential pre-requisite in a screening method. At 
intermediate spiking concentrations the bias ranged from −5.4% (morphine) to +18.0% (MDEA), 
whereas at the highest concentration level the upper and lower limits were +0.5% 
(benzoylecgonine) and −13.8% (MDMA). On the whole, all the experimental bias values were 
largely below the acceptable limit of ±25% at all concentrations. Only for methamphetamine, the 
intra-day accuracy calculated at LOQ showed a significant overestimation (+47.5%). 
At the intermediate concentration level (1.0 ng/mg for all analytes, 0.2 ng/mg for Δ9-THC), also the 
inter-day precision proved satisfactory, as the CV% values ranged from 8.1% for codeine to 22.5% 
for MDEA, likewise the intra-day accuracy, ranging from −8.4% to +19.6. As for intra-day results, 
also inter-day precision data calculated at LOQ were satisfactory for all compounds while 
methamphetamine, MDMA and methadone were largely overestimated. This does not represent a 
limit to the applicability of the method, since a screening method requires a more accurate 
quantification at cut-off levels rather than at LOQs. 
 
3.1.6. Carry-over 
The background chromatographic profiles of the main transitions for each analyte, monitored 
during the analysis of blank urine injected after highly spiked samples, did not show the presence 
of any significant signal (i.e. the S/N value was always <3) at the retention times expected for the 
tested analytes. Therefore, the occurrence of carry-over effects was excluded. 
 
3.1.7. Application to real cases 
Our laboratory is continuously using the present screening method for the routine analysis of real 
samples, mainly from driving re-licensing, drug abuse history and withdrawal control, post-mortem 
toxicology. When one or more of the molecules included in this screening are identified, a 
confirmation analysis is usually performed. In 2011, this fast and comprehensive screening method 
allowed us to manage a load of 3832 samples (head, pubic, axillary or chest hair). We also 
successfully participated to external Proficiency Tests including those organized by the Society of 
Hair Testing, GTFCh and Istituto Superiore di Sanità (Rome, Italy). 
The two following examples of multiple positive identifications are reported, in order to demonstrate 
the practical usefulness and general applicability of this method. In Fig. 2 a chromatogram of a 
sample positive to MDMA, cocaine, BZE and methadone is reported. In Fig. 3 a chromatogram of a 
sample positive to morphine, 6-MAM, codeine and THC is reported. 
 
 










A simple and fully validated procedure is described for the simultaneous screening and 
determination in hair samples of morphine, 6-acetylmorphine, codeine, amphetamine, 
methamphetamine, 3,4-methylenedioxyamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-
methylenedioxyethylamphetamine, benzoylecgonine, cocaine, buprenorphine, methadone and Δ9-
tetrahydrocannabinol. The main features of the proposed method are the speed of sample 
processing, the wide range of drugs considered and the comprehensive analytical sensitivity 
toward them. The ease of sample treatment, together with the simultaneous determination of 
multiclass substances, including THC, in a single run of 5.5 min plus 2.5 min of column re-
equilibration time, make the procedure highly effective for large sample loadings. The modern SRM 
technique and instrumentation provided improved sensitivity, allowing us to avoid the sample pre-
concentration step and resulting in a drastic reduction of sample handling. On the other hand, the 
utilization of UHPLC–MS/MS technology drastically reduced the time required for instrumental 
analysis, without sacrificing the chromatographic resolution, nor the accuracy and precision for 
quantitative determinations. 
In general, high sample throughput achievable by the present method considerably reduces the 
overall analysis cost, including investment pay-back, making it affordable, especially for public 
administrations, in workplace testing. Moreover, the analytical performances are high and relatively 
uniform for all the studied analytes, so that the present protocol may find easy application in routine 
analysis for toxicological investigations. 
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